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Abstract
Streptococcus suis (SS) is a zoonotic pathogen that causes severe disease symptoms in pigs and humans. Biofilms of SS bind
to extracellular matrix proteins in both endothelial and epithelial cells and cause persistent infections. In this study, the
differences in the protein expression profiles of SS grown either as planktonic cells or biofilms were identified using
comparative proteomic analysis. The results revealed the existence of 13 proteins of varying amounts, among which six
were upregulated and seven were downregulated in the Streptococcus biofilm compared with the planktonic controls. The
convalescent serum from mini-pig, challenged with SS, was applied in a Western blot assay to visualize all proteins from the
biofilm that were grown in vitro and separated by two-dimensional gel electrophoresis. A total of 10 immunoreactive
protein spots corresponding to nine unique proteins were identified by MALDI-TOF/TOF-MS. Of these nine proteins, five
(Manganese-dependent superoxide dismutase, UDP-N-acetylglucosamine 1-carboxyvinyltransferase, ornithine carbamoyl-
transferase, phosphoglycerate kinase, Hypothetical protein SSU05_0403) had no previously reported immunogenic
properties in SS to our knowledge. The remaining four immunogenic proteins (glyceraldehyde-3-phosphate
dehydrogenase, hemolysin, pyruvate dehydrogenase and DnaK) were identified under both planktonic and biofilm growth
conditions. In conclusion, the protein expression pattern of SS, grown as biofilm, was different from the SS grown as
planktonic cells. These five immunogenic proteins that were specific to SS biofilm cells may potentially be targeted as
vaccine candidates to protect against SS biofilm infections. The four proteins common to both biofilm and planktonic cells
can be targeted as vaccine candidates to protect against both biofilm and acute infections.
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Introduction
Streptococcus suis (SS) is a major worldwide pathogen and
colonizes the respiratory tract of pigs, particularly the tonsils and
nasal cavities [1]. SS is believed to be a normal inhabitant of
several ruminants [2]. SS binds to the extracellular matrix (ECM)
proteins, including fibronectin and collagen [3], of endothelial and
epithelial cells [4,5]. Some studies have demonstrated that SS has
the ability to form biofilms [6,7]. The biofilm mode of growth
affords SS several advantages over its planktonic counterparts,
including the capability of ECM to trap nutrients and protect
against both antimicrobial agents and the host immune responses
[6,7]. Our previous studies indicate that SS maybe achieve
persistent infections in vivo by forming biofilms [8] and hence SS
infections might be difficult to treat. Biofilms play a key role in the
pathogenesis and persistence of several bacterial infections [9]. It
has been postulated that an altered metabolism and changes in
gene expressions and protein amounts in biofilms may be
responsible for drug resistance, cell adherence and virulence.
Recent results indicate that biofilm cells have an active, although
altered cell metabolism [10,11]. Considerable investigation is
required to gain a better understanding of biofilm formation.
Previous studies have investigated different immunogenic
components of planktonically grown SS proteins; e.g., secreted
or cell wall associated proteins using immunoproteomic assays
[12,13,14,15]. Zhang et al. reported that 11 membrane-associated
proteins and nine extracellular proteins are immunogenic proteins
using the hyperimmune or convalescent serum of minipigs [12,13].
Geng et al. identified 32 proteins with high immunogenicity of
which 22 were not previously reported [14]. Zhang et al. identified
a total of 34 proteins by immunoproteomic analysis, of which 15
were recognized by both hyperimmune sera and convalescent sera
[15]. At present, little is known about proteins targeted by the host
immune system in the case of biofilm-mediated infections.
Identifying those SS proteins that are targeted by the host
immune system would increase the understanding of host defense
mechanisms and help to identify novel means of diagnosis and
treatment for pigs with persistent infections. Identification of these
immunogenic antigens is necessary for effective vaccine design and
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formation by SS.
In this study, the differences in the whole cell protein
expressions of SS cultivated under biofilm versus planktonic
conditions were investigated. We utilized a convalescent mini-pigs
model of challenged SS and an in vitro biofilm growth system to
identify the immunogenic antigens of SS biofilm infections. We
identified several proteins unique to SS grown as biofilms and
planktonic cells by employing two-dimensional gel electrophoresis
(2DGE) and matrix-assisted laser desorption ionization–time of
flight–time of flight mass spectrometry (MALDI-TOF/TOF-MS)
analysis.
Materials and Methods
Bacteria and Culture Conditions
SS2 strain clinical isolate HA9801 was used in this study. This
strain was isolated by our laboratory in Jiangsu, China in 1998 and
has the ability to form biofilms [8]. For biofilm cultures, SS was
grown in THB medium (Oxoid, Wesel, Germany) supplemented
with 1% fibrinogen in 100 mm polystyrene petri dishes at 37uC for
24 h. The supernatant was then removed and the plates were
rinsed twice with 50 mM Tris/HC1 (pH 7.5). Biofilms were
detached by scraping. Cells were sonicated for 5 min (Bransonic
220; Branson Consolidated Ultrasonic Pvt Ltd, Australia),
followed by centrifugation at 12,000 6g for 10 min at 4uC and
the supernatant was discarded. Cell pellets were washed twice with
50 mM Tris-HC1 (pH 7.5) by resuspending pellets with vortexing
and collected by centrifugation 12,000 6g for 10 min at 4uC. SS
planktonic cell was grown in 500 Erlenmeyer flasks containing
100 ml of the above culture medium at 37uC for 24 h. Planktonic
cells were pelleted and washed as described above.
Extraction of Proteins from SS Cells
Protein was extracted from SS cells as described by Rathsam
[16] with minor modifications. Briefly, the SS cell pellets from
biofilm and planktonic cultures were resuspended in buffer (Tris-
HCl, MgCl2, 50% sucrose) supplemented with 1000 U/ml
Mutanolysin (Sigma) and were incubated for 90 min at 37uC.
The spheroplasts were collected and resuspended by sonication on
ice at 100W for 90 cycles of (5 s on, 10 s off) using a sonication
buffer (7 M urea, 2 M thiourea, 4% CHAPS, and 65 mM DTT),
and incubated at 25uC for 30 min. The cell debris and unbroken
cells were removed by centrifugation at 10,000 6g for 30 min at
25uC. The proteins in the supernatant were precipitated using
10% TCA at 4uC for 30 min. Precipitated protein was collected by
centrifugation at 10,000 6g for 10 min at 4uC and washed twice
with chilled acetone. The final pellet was air-dried. The dried
pellet was dissolved in sample preparation solution, then incubated
for 30 min at 25uC (vortexed every 10 min) and centrifuged at
10,000 6g for 20 min at 25uC. Before rehydration, the
supernatant was treated with a 2-D Clean-up Kit (GE Healthcare)
to remove contaminants that can interfere with electrophoresis.
The protein content was determined using the PlusOne 2-D
Quant Kit (GE Healthcare) following manufacturer’s directions.
2-D Gel Electrophoresis
2DGE was performed using the immobiline/polyacrylamide
system. Isoelectric focusing (IEF) was performed with IPG
Drystrips (IPGphor; 13 cm; GE Healthcare) with 200mg of the
protein sample using the in-gel sample rehydration technique
according to the manufacturer’s instructions. IEF was performed
in a Protein IEF Cell (GE Healthcare) using a stepwise voltage
gradient to 80 kVh. Before the second dimension, strips were
equilibrated for 2615 min in equilibration buffer (6 M urea, 2%
SDS, 30% glycerol, 0.05 M Tris–HCl pH 8.8), containing 1%
DTT and 4% iodoacetamide, respectively. SDS-PAGE was
carried out vertically in an Ettan DALT II system (GE Healthcare)
using 12.5% polyacrylamide gels. Resolved proteins were stained
with Coomassie Brilliant Blue G-250 stain for identifying the
protein bands. All experiments were performed in triplicate.
Reproducibility of the 2DGE was verified by analyzing the same
samples at least three times on independent gels. Three replicate
gels from three independent experiments were analyzed for each
growth condition. The gels were analyzed using the Image Master
Platinum 5.0 software (GE Healthcare). The normalized protein
amount for each protein spot was calculated as the ratio of that
spot volume to the total spot’s volume on the gel. Either Student t-
test (P , 0.05) or a threshold of 2-fold change was used to
determine significant difference between the two groups.
Preparation of Convalescent Sera
Five specific pathogen free mini-pigs were injected with SS
(1.0610
8 CFU/mL, 1 mL/pig, intramuscularly). As a control,
preimmune sera were collected from mini-pigs before SS injection.
Twenty days after the first injection, the survivor was again
injected with second (identical) dose of SS. Serum was collected
seven days after the second injection. The OD of the serum from
pig injected with SS2 was 0.9360.15 and the OD of the
preimmune sera was 0.26 6 0.05. The titers of the convalescent
sera were evaluated by ELISA (unpublished protocol), and the sera
with high titer was selected for subsequent experiments. All animal
experimental protocols were approved by Science and Technology
Agency of Jiangsu Province (SYXK-SU-2010-0005).
Western Blotting
Protein samples from the 2DGE were transferred onto a PVDF
membrane (GE Healthcare) using a semi-dry blotting apparatus
(TE77, GE Healthcare) for 2 h at 0.65 mA/cm
2. After transfer,
the membrane was blocked with 100 mM Tris, 150 mM NaCl,
0.05% Tween-20 (TBST), containing 5% dry milk powder for 2 h.
The blocked-membrane was then incubated with sera from either
preimmune or convalescent mini-pigs (1:1000 dilution) for 2 h at
room temperature with gentle agitation. The membrane was
washed three times with TBST buffer for 10 min per wash and
incubated with horseradish peroxidase-labeled Staphylococcal
protein A (Boster, Nanjing, China), (1:5000 dilution) in blocking
buffer for 1 h with gentle agitation. The membrane was washed as
described above. The membranes were incubated with DAB
substrate (Tiangen, Nanjing, China) for 10 min. Each sample was
analyzed three times by western blot.
Mass Spectrometry Analysis of Protein Spots and
Database Searches
Differential expression spots and immune-reactive proteins were
excised from the 2-D gels and sent to the Shanghai Applied
Protein Technology Co. Ltd for trypsin in-gel digestion and
MALDI-TOF-MS analysis. Protein spots with a low Mascot score
were further analyzed using MALDI-TOF/TOF-MS to confirm
identity. Data from MALDI-TOF-MS and MALDI-TOF/TOF-
MS analysis were used in a combined search against the NCBInr
protein database using MASCOT (Matrix Science) with the
parameter settings of trypsin digestion, one max missed cleavages,
variable modification of oxidation (M), and peptide mass tolerance
for monoisotopic data of 100 ppm. Originally, the MASCOT
server was used against the NCBInr for peptide mass fingerprint-
ing (PMF). The criteria used to accept protein identifications were
Identified Biofilm Immunogenic Proteins
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e33371based on PMF data, namely the extent of sequence coverage,
number of peptides matched, and score of probability. Protein
identification was assigned when the following criteria were met:
presence of at least four matching peptides and sequence coverage
was greater than 15%.
Reverse Transcription (RT)-PCR
Total RNA was isolated from SS grown as biofilms and
planktonic cells for 24 h with an E.Z.N.A.
TM bacterial RNA
isolating kit (Omega, Beijing, China) following manufacturer’s
directions. The RNA was subjected to DNase I (Promega,
Madison, USA) treatment to remove DNA contaminantion. The
cDNA synthesis was performed using the PrimeScript
TM RT
reagent kit (TaKaRa, Shanghai, China) following manufacturer’s
directions. mRNA levels were measured using two-step relative
qRT-PCR. Relative mRNA amounts and expression ratios of
selected genes were normalized to the expression of 16S rRNA
mRNA amounts and fold changes were calculated as described by
Gavrilin et al. [17]. A specific primer set was used to analyze
GAPDH (F; 59-CTTGGTAATCCCAGAATTGAACGG-39 and
R; 59- TCATAGCAGCGTTTACTTCTTCAGC-39), MRP (F; 59-
CAAGGAAAGTGAACAGAACGAGC-39 and R; 59-T A G T C -
GTCCAAACCTGAGTAGCG-39)a n d1 6 Sr R N A( F ;5 9-GTTGC-
GAACGGGTGAGTAA-39 and R; 59-TCTCAGGTCGGCTAT-
GTATCG-39) mRNA content using the the SYBR Premix Ex
Taq
TM Kit (Takara, Shanghai, China) following manufacturer’s
instructions. Reactions were carried out in triplicate. An ABI 7300
RT-PCR system was used for relative qRT-PCR.
Results
Comparative Proteomics
2DGE of proteins from SS grown as biofilms or planktonic cells
was performed to characterize the differences in protein expression
between the two groups. The representative 2DGE images of
biofilm and planktonic cells are provided in Figure 1. The majority
of proteins were distributed in the range of pI 4–7 (Figures 1A and
B). A total of 15 dominant protein spots were different between SS
grown as biofilms or planktonic cells. MALDI-TOF-MS or
MALDI-TOF/TOF-MS analysis identified 15 protein spots
corresponding to 13 individual proteins. The probability score
for the match, molecular weight (MW), isoelectric point (pI),
number of peptide matches and the percentage of the total
translated ORF sequence covered by the peptides were used as
confidence factors in protein identification.
The proteins that were upregulated by more than two-fold
included glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 (MurA),
pyruvate dehydrogenase E1 component (PDH), ornithine carba-
moyltransferase (OTC), hypothetical protein SSU05_0403 and
enoyl-CoA hydratase (Table 1). The proteins that were downreg-
ulated included ABC transporter periplasmic-binding protein
(MntC), fructose-bisphosphate aldolase (FBA), dpr, BAA, muram-
idase-released protein (MRP), triosephosphate isomerase and
elongation factor Tu (ET-Tu) (Table 2).
Immunoreactive Proteins
Ten immunoreactive protein spots were observed on the
immunoblot of SS biofilm whole-cell proteins (Figure 2B) that
matched the protein spots observed in the 2DGE gel (Figure 2A).
When the blot was probed with preimmune sera, no specific
immunoreactive protein spots were observed (Figure 2C). A total
of 10 immunoreactive protein spots, corresponding to nine unique
proteins, namely GAPDH, MurA, PDH, OTC, manganese-
dependent superoxide dismutase (SodA), hypothetical protein
SSU05_0403, molecular chaperone DnaK, hemolysin and
phosphoglycerate kinase were identified (Table 3). Of these nine
proteins, five (SodA, MurA, OTC, SSU05_0403, and phospho-
glycerate kinase) have not been previously reported as immuno-
reactive proteins in SS to our knowledge. The remaining four
immunogenic proteins (hemolysin, GAPDH, PDH and DnaK)
have been identified in both planktonic and biofilm growth
conditions in previous reports [12,13,14,15].
Confirmation of Comparative Proteomics Results by
Quantitative Real-time PCR
Quantitative real-time PCR was performed on two selected
genes to confirm the results of comparative proteomics analysis.
We selected one upregulated gene (GAPDH) and one downreg-
ulated gene (MRP) in SS grown as biofilms. The qRT-PCR results
confirmed the results of comparative proteomic analysis. SS grown
as biofilms had 2.2 times higher GAPDH mRNA (P , 0.01) and
Figure 1. 2D gel electrophoresis patterns of Streptococcus suis (SS) from whole cell lysate proteins. SS was grown as biofilms and
planktonic conditions and the proteins separated by 2DGE. The proteins were separated in the first dimension by IEF (pH range 4-7) and in the
second dimension by SDS-polyacrylamide gel electrophoresis. Molecular weight markers are on the left lane (kDa). (A) Protein pattern in the
planktonic culture. (B) Protein pattern in the biofilm culture. Red arrow heads represent protein spots with a significantly (P , 0.05) increased amount
in each culture mode.
doi:10.1371/journal.pone.0033371.g001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e333710.3 times lower MRP mRNA amounts (P , 0.05) than SS grown
as planktonic cells (Figure 3).
Discussion
In this study, the differences in the whole-cell protein
expressions of SS grown under either biofilm or planktonic
conditions were analyzed to reveal several differences in protein
expressions between the two groups. Thirteen proteins, which
showed differential expression under conditions of biofilm growth,
were identified. Of the 13 proteins, six proteins were up-regulated
and seven proteins were down-regulated in the biofilm proteome.
Similar results have been demonstrated using other bacteria
[18,19,20,21]. For example, nine proteins are up-regulated in the
streptococcus mutans biofilm cells compared with the planktonic cells
[16]. Similarly, Alen et al. reported that eight proteins are up-
regulated and four proteins are down-regulated in the Neisseria
meningitidis biofilm [22]. In this study, though some other proteins
were either down-regulated or up-regulated between the two
groups, we only chose the 13 proteins because these 13 proteins
were consistently different between triplicate gels. Using proteins
from the biofilm cells and immunoblotting with convalescent sera,
nine immunogenic proteins were identified. Only a limited
number of proteins were identified, which may be due to serum
being collected at early stages of infection in this study. Serum
collected at late stages of infections identifies more protein spots
[23].
Although bacteria in biofilms exhibit persistence in spite of
sustained host defenses, little is known about the host immune
response to biofilm infections. Protein expression in biofilms grown
in vivo cannot be easily studied because it is difficult to extract
bacterial proteins from in vivo grown biofilms. Certain antibodies
may prevent biofilm development. For example, an antibody to an
outer membrane protein in Pseudomonas aeruginosa was recently
shown to inhibit biofilm formation by interfering with adhesion to
the surface [23]. We employed a system in which mini-pigs were
challenged with SS. By collecting sera from these mini-pigs during
the course of infection and utilizing these sera to probe
immunoblots of protein isolated from the in vitro-grown biofilm,
we were able to visualize those immunogenic proteins that were
present during biofilm infection. Though there are studies
describing the immunogens present on the surface of planktonic
SS, the data presented in this paper are the first to describe
biofilm-specific proteins recognized by host antibodies. We found
10 immunoreactive spots that corresponded to nine individual
immunogenic proteins. It was very interesting that five identified
immunogenic proteins were up-regulated in the Streptococcus
biofilm. A similar result has been found in S. aureus, where
approximately 76% of the immunogenic proteins were upregu-
lated in at least one of the stages of biofilm formation during in vitro
growth [23]. Previous studies have evaluated the immunogenicity
of SS proteins in planktonic growth conditions [13,14,15].
However, these studies failed to detect the biofilm-associated
antigens found in this work, with the exception of hemolysin,
GAPDH, PDH and DnaK. The above four common immuno-
genic proteins were identified in both growth conditions and hence
could be promising vaccine candidates to prevent both biofilm
infections and acute infections. The remaining immunoreactive
proteins in SS2 found in this study have not been previously
reported to our knowledge.
Figure 2. Gel electrophoresis of Streptococcus suis (SS) grown as biofilm cells with the immunoreactive proteins indicated. Preparative
2D gel of proteins from SS grown as biofilms and stained with CBB (A) or with western blot using convalescent serum (B) or preimmune sera (C). The
identified proteins are indicated by pot number in Fig. 2A and B and Table 3. Molecular weight markers are on the left in kDa.
doi:10.1371/journal.pone.0033371.g002
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e33371Future studies should focus on identifying the role of GAPDH,
MntC, OTC, FBA and PDH in biofilm formation, because
Puttamreddy reported that biofilm formation and cellular
adherence to epithelial cells are interlinked [24]. A previous study
showed that these proteins could mediate cell adherence. GAPDH
and MntC mutant strains confirmed the speculation [25].
Therefore, it is reasonable to think that other proteins might be
involved in biofilm formation of SS. Study of the other proteins is
ongoing in our laboratory to check if they are related to biofilm
formation.
GAPDH is a glycolytic enzyme responsible for the conversion of
glyceraldehyde 3-phosphate into 1,3-diphosphoglycerate. GAPDH
is a SS surface protein and mediates cell adhesion and plays an
important role in bacterial infection and invasion [26,27].
GADPH was upregulated in SS grown as biofilms. Similarly,
biofilms of Pseudomonas aeruginosa [28] and Staphylococus xylosus [29]
upregulate GAPDH. This also resembles the regulation of the
enzyme in E. coli K12 under microaerobic conditions [30], which
is indirectly linked to oxygen limitation in biofilms. Furthermore,
SS mutants with GAPDH knocked-out had decreased ability to
form biofilms (data not shown). It has also been reported that
GADPH is an immunogenic protein found on the cell wall of SS
[15]. GAPDH is reported in the development of subunit vaccines
against Edwardsiella tarda [31,32], Streptococcus pneumoniae [33] and
Bacillus anthracis [34].
The protein from spot BF8 matched SS OTC. OTC is a key
enzyme in the urea cycle and detoxifies ammonium produced
from amino acid catabolism [35,36]. In Bacillus cereus, OTC was
upregulated in biofilm cells at 18 h of culture. This may be
indicative of oxygen depletion in microcolonies, or alternatively, it
may indicate that the attached cells were preparing for growth
within a biofilm before the conditions became anoxic. OTC is a
putative adhesin for Staphylococcus epidermidis [37] and has been
identified as an immunogenic protein from the outer surface
protein preparations of S. agalactiae, S. pyogenes and Clostridium
perfringens [38].
MntC is part of the MntABC transporter and is involved in
oxidative stress defense in Nisseria gonorrhoeae and Nisseria meningitidis
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Figure 3. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and Muramidase-released protein (MRP) mRNA
amounts in Streptococcus suis grown as biofilms and planktonic
cells. The mRNA content was analyzed by RT-PCR after adjusting for
16S rRNA mRNA content. The comparative cycle threshold method
(2
2DDCT method) was used to analyze the mRNA levels. Results are
shown as fold changes compared to expression in the planktonic cell.
Datas are the mean 6 SEM for the results of three independent analysis.
doi:10.1371/journal.pone.0033371.g003
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e33371[39]. The N. gonorrhoeae MntC knock-out is more sensitive to
oxygen killing, and accumulate less manganese than the wild type
[39]. Furthermore, the gonococcal MntC knock-out have reduced
intracellular survival and have reduced ability to form biofilms
[25]. MntC facilitates biofilm formation of Gonococci, and affects
the colonization of mice [40]. Alen et al. reported that biofilm
formation is almost completely abrogated in the MntC mutants of
Neisseria meningitides [22].
PDH converts pyruvate to acetyl coenzyme A, which is
subsequently used in the tricarboxylic acid cycle to generate
NADH, ATP, and reduced flavin adenine dinucleotide [41].
Welin et al. [42] and Korithoski et al. [43] used 2DGE to reveal
that PDH is upregulated 2.5-fold in S.mutans biofilm cells. PDH is
thought to play a role in the binding to fibronectin [44]. PDH is an
important part of the cytoskeleton of M. pneumoniae and is linked to
cell adhesion [45]. PDH is highly immunogenic in other bacterial
species, such as N. meningitidis [46], Mycoplasma capricolum [47] and
M. hyopneumoniae [48]. Recently, PDH has been tested as a DNA
vaccine against M. mycoides subsp. mycoides, the causal agent of
contagious bovine pleuropneumonia [49].
The upregulation of SodA involved in detoxification of ROS
was in line with proteomic and microarray studies in biofilms of
other bacteria; e.g., Staphylococcus aureus and Neisseria meningitidis
[10,22]. SodA has a role in the protection of group A
streptococcus challenge [50]. A similar result was shown with
Listeria monocytogenes [51], Brucella abortus [52] and Escherichia coli
[53]. Recombinant SodA elicits strong antibody responses in mice
[53].
MurA is a key enzyme involved in bacterial cell wall
peptidoglycan synthesis and a target for the antimicrobial agent,
fosfomycin. Increased expression of MurA in the biofilms may
contribute to the increased drug resistance [54].
The BLASTx search identified IP11 as molecular chaperone
DnaK, IP12 as hemolysin and BF13 as phosphoglycerate kinase.
DnaK is an important immunogen in S. pneumoniae [55] and S.
pyogenes [56]. Hemolysin is a secreted protein and is a bacterial
virulence factor [57]. Phosphoglycerate kinase is a major outer
surface protein of S. suis. The above three proteins have been
reported to be immunogenic in SS [13].
In this study, most of the downregulated genes such as FY1,
FY2, FY4, FY5, FY6, FY7, and FY8 are likely to be involved in
protein synthesis or encode membrane proteins/transporters
(Table 2). This reduced level of expression may indicate a limited
bacterial growth rate and that the SS organisms in biofilm
environments have limited but more specific metabolic activity.
Among the down-regulated genes was FY2 which represents
fructose-bisphosphate aldolase. Fructoses are extracellular storage
compounds and can act as binding sites for bacterial adhesion
[58,59]. Extracellular fructans play a role in sucrose-dependent
bacterial adherence and biofilm accumulation. To down-regulate
this sucrose-dependent cell–cell adhesion, biofilm formation gene
in biofilm cells makes bio-economic sense since sucrose is absent in
the environment. FBA and MRP are virulence factors in a variety
of organisms [60]. The expression of virulence factors in the
planktonic cells will make the planktonic cells more virulent and,
therefore, cause acute infections than biofilm cells [61]. In our
previous study, biofilm cells had lower virulence when compared
to planktonic cells in an animal model. In addition some virulence
genes were downregulated in biofilm cells [8]. Changes in the
structure of the bacteria may alter the expression levels of
virulence genes. Biofilm cells are wrapped by a polysaccharide
complex, which would influence the virulence factors secreted
from the bacteria.
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